Early Therapy Evaluation of Combined Cetuximab and Irinotecan in Orthotopic Pancreatic Tumor Xenografts by Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Early pancreatic cancer response following cetuximab and/or irinotecan therapies was measured by serial dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) before and during therapy. Groups 1 to 4 ( n = 6/group) of SCID mice bearing orthotopic pancreatic adenocarcinoma xenografts expressi...
Saved in:
Main Authors: | Hyunki Kim, Karri D. Folks, Lingling Guo, Jeffery C. Sellers, Naomi S. Fineberg, Cecil R. Stockard, William E. Grizzle, Donald J. Buchsbaum, Desiree E. Morgan, James F. George, Kurt R. Zinn |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-05-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2010.00040 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
by: Maria Ignez Freitas Melro Braghiroli, et al.
Published: (2024-01-01) -
Antitumor Activity of Intratumoral Ethanol Injection in an Orthotopic Pancreatic Cancer Cell Mouse Xenograft Model
by: Wen-Ying Zhang, et al.
Published: (2018-01-01) -
Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance
by: Hyun Joo Jang, et al.
Published: (2016-01-01) -
Editor’s Note: Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer
Published: (2025-01-01) -
Glucose Metabolism of Human Prostate Cancer Mouse Xenografts
by: Hossein Jadvar, et al.
Published: (2005-04-01)